| Product Code: ETC7626395 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Chronic Obstructive Pulmonary Disease Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Chronic Obstructive Pulmonary Disease Market - Industry Life Cycle |
3.4 Ireland Chronic Obstructive Pulmonary Disease Market - Porter's Five Forces |
3.5 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Chronic Obstructive Pulmonary Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of smoking and air pollution in Ireland leading to a rise in cases of chronic obstructive pulmonary disease (COPD) |
4.2.2 Advancements in medical technology and treatment options for COPD patients |
4.2.3 Growing awareness and focus on respiratory health by healthcare providers and policymakers |
4.3 Market Restraints |
4.3.1 High cost of COPD treatments and medications impacting affordability for patients |
4.3.2 Limited access to specialized healthcare facilities and pulmonary rehabilitation programs in certain regions of Ireland |
4.3.3 Lack of early diagnosis and screening programs for COPD leading to delayed treatment and management |
5 Ireland Chronic Obstructive Pulmonary Disease Market Trends |
6 Ireland Chronic Obstructive Pulmonary Disease Market, By Types |
6.1 Ireland Chronic Obstructive Pulmonary Disease Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Chronic Bronchitis, 2021- 2031F |
6.1.4 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Emphysema, 2021- 2031F |
6.2 Ireland Chronic Obstructive Pulmonary Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.3 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Bronchodilator Monotherapy, 2021- 2031F |
6.2.4 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Short-Acting Beta2-Agonists (SABAS), 2021- 2031F |
6.2.5 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Long-Acting Beta2-Agonists (LABAS), 2021- 2031F |
6.2.6 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Anti-Cholinergic Agents, 2021- 2031F |
6.2.7 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Anti-Inflammatory Drugs, 2021- 2031F |
6.2.8 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Chronic Obstructive Pulmonary Disease Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.3.4 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.5 Ireland Chronic Obstructive Pulmonary Disease Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Chronic Obstructive Pulmonary Disease Market Import-Export Trade Statistics |
7.1 Ireland Chronic Obstructive Pulmonary Disease Market Export to Major Countries |
7.2 Ireland Chronic Obstructive Pulmonary Disease Market Imports from Major Countries |
8 Ireland Chronic Obstructive Pulmonary Disease Market Key Performance Indicators |
8.1 Average age of COPD diagnosis in Ireland |
8.2 Number of COPD-related hospital admissions per year |
8.3 Percentage of COPD patients enrolled in pulmonary rehabilitation programs |
8.4 Rate of adherence to COPD treatment plans |
8.5 Number of healthcare professionals trained in COPD management and care |
9 Ireland Chronic Obstructive Pulmonary Disease Market - Opportunity Assessment |
9.1 Ireland Chronic Obstructive Pulmonary Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Chronic Obstructive Pulmonary Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Ireland Chronic Obstructive Pulmonary Disease Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Chronic Obstructive Pulmonary Disease Market - Competitive Landscape |
10.1 Ireland Chronic Obstructive Pulmonary Disease Market Revenue Share, By Companies, 2024 |
10.2 Ireland Chronic Obstructive Pulmonary Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here